WFC Stock Recent News

Wells Fargo has suspended all travel to China after a banker was blocked from leaving the country, a source said, bringing the U.S. bank's operations in the world's second-largest economy into focus.

Fears that employees of foreign firms risk entanglement with Chinese authorities have resurfaced after news that an employee of U.S. bank Wells Fargo has been banned from leaving the country.

Wall Street is humming thanks to a boom in stock and bond trading and a pickup in corporations acquiring competitors and taking out massive loans. At the same time, Main Street is holding up as the American consumer continues to spend, borrow and repay loans, according to reports this week from the largest U.S. banks.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Wells Fargo (WFC) have what it takes?

Note: The following is an excerpt from this week's Earnings Trends report. You can access the full report that contains detailed historical actual and estimates for the current and following periods, please click here>>>

Note: The following is an excerpt from this week's Earnings Trends report. You can access the full report that contains detailed historical actual and estimates for the current and following periods, please click here>>>

Live Updates Live Coverage Updates appear automatically as they are published. Today's Wall Street Updates on Bank Stocks 9:20 am Ticker Company Analyst Firm Rating (Unchanged) New Price Target (Old) Reasons C Citigroup Barclays Overweight $100 ($95) Q2 earnings beat estimates; NII ahead, though fees worse; pointed to 2025 revenues at high-end of guidance, offset by slight expense increase. C Citigroup Morgan Stanley Overweight $107 ($103) High-quality EPS beat; raised guidance; doubled share repurchases to at least $4B in Q3; expects 10% ROTCE in 2026. C Citigroup Piper Sandler Overweight $104 ($84) Increasing EPS estimates post-Q2; story checks all right boxes as a winner this quarter. JPM JPMorgan Morgan Stanley Equal Weight $298 ($296) Strong 11% EPS beat vs. consensus; raised NII guidance; highlighted potential uses of excess capital, including inorganic opportunities (high bar). BK BNY Mellon Morgan Stanley Overweight $101 ($95) 11% EPS beat driven by fees and NII; sixth str

Live Updates Live Coverage Updates appear automatically as they are published. Upgrades and Downgrades for Bank Stocks 9:23 am Ticker Company Analyst Firm Rating (Unchanged) New Price Target (Old) Reasons C Citigroup Barclays Overweight $100 ($95) Q2 earnings beat estimates; NII ahead, though fees worse; pointed to 2025 revenues at high-end of guidance, offset by slight expense increase. C Citigroup Morgan Stanley Overweight $107 ($103) High-quality EPS beat; raised guidance; doubled share repurchases to at least $4B in Q3; expects 10% ROTCE in 2026. C Citigroup Piper Sandler Overweight $104 ($84) Increasing EPS estimates post-Q2; story checks all right boxes as a winner this quarter. JPM JPMorgan Morgan Stanley Equal Weight $298 ($296) Strong 11% EPS beat vs. consensus; raised NII guidance; highlighted potential uses of excess capital, including inorganic opportunities (high bar). BK BNY Mellon Morgan Stanley Overweight $101 ($95) 11% EPS beat driven by fees and NII; sixth straight qu

Live Updates Live Coverage Updates appear automatically as they are published. Goldman Sachs Results Are out 7:54 am by Eric Bleeker Need-to-Know Numbers: Revenue: $14.58 billion (tops estimates of $13.58 billion) EPS: $10.91 (tops estimates of $9.62) Goldman Sachs reported its second quarter 2025 earnings, revealing net revenues of $14.58 billion and net earnings of $3.72 billion. The diluted earnings per share (EPS) for the quarter was $10.91, a notable increase from $8.62 in the same quarter last year, but a decrease from $14.12 in the previous quarter. The firm also announced an increase in its quarterly dividend to $4.00 per common share, effective in the third quarter. The annualized return on average common shareholders’ equity was 12.8% for the quarter. The company’s book value per common share rose by 1.6% during the quarter to $349.74. Despite a slight decline in net revenues compared to the first quarter of 2025, Goldman Sachs showed a strong performance in its Globa

SAN FRANCISCO--(BUSINESS WIRE)--Wells Fargo Commercial Banking has aggressively expanded its team of healthcare industry bankers by more than 30% since the start of 2025, with more hires expected in the second half of the year. The team's expansion is being fueled by continued growth in the U.S. healthcare sector, coupled with client demand for specialized coverage. This is the largest investment in talent Commercial Banking has made to date in the Healthcare Banking group, which provides indus.